Literature DB >> 31303604

Orbital Atherectomy Via Transradial Access: A Multicenter Propensity-Matched Analysis.

Rajkumar Doshi1, Evan Shlofmitz, Rajiv Jauhar, Perwaiz Meraj.   

Abstract

AIMS: The main objective of this study was to assess the safety and feasibility of orbital atherectomy (OA) with transradial access compared with more traditional femoral access.
METHODS: This multicenter, observational study included five tertiary-care centers. Out of the 39,870 who underwent percutaneous coronary intervention between January 2011 and January 2017, a total of 433 patients treated with coronary OA were identified and divided in two groups based on arterial access site. The co-primary outcomes of this study were major bleeding, associated blood transfusion, and safety outcomes. A propensity score was generated to match for baseline characteristics to avoid potential selection bias.
RESULTS: Transradial access was associated with significantly reduced major bleeding and blood transfusion in both the unadjusted model (0.6% vs 4.4% [P=.02] and 0.6% vs 4.8% [P=.02], respectively) and the propensity-score matched model (0.8% vs 6.5% [P=.045 for both]). There were no differences in safety outcomes, contrast use, fluoroscopy time, or any other secondary outcomes.
CONCLUSIONS: In this real-world, multicenter, observational study, OA via transradial access was both safe and feasible. Furthermore, transradial access was associated with reduced bleeding complications and associated blood transfusion when compared with femoral access.

Entities:  

Keywords:  transfemoral; transradial access; calcified coronary artery; orbital atherectomy

Mesh:

Year:  2019        PMID: 31303604

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  1 in total

1.  Coronary Intravascular Lithotripsy Versus Rotational Atherectomy in an Asian Population: Clinical Outcomes in Real-World Patients.

Authors:  Jie Jun Wong; Sridharan Umapathy; Yann Shan Keh; Yee How Lau; Jonathan Yap; Muhammad Idu; Chee Yang Chin; Jiang Ming Fam; Boon Wah Liew; Chee Tang Chin; Philip En Hou Wong; Tian Hai Koh; Khung Keong Yeo
Journal:  Korean Circ J       Date:  2021-11-29       Impact factor: 3.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.